Structures by: Egert E.
Total: 107
C4H4FN3O,C4H6N4O,C3H7NO
C4H4FN3O,C4H6N4O,C3H7NO
Acta Crystallographica Section B (2012) 68, 4 431-443
a=9.0866(14)Å b=9.3632(15)Å c=9.4019(15)Å
α=104.720(13)° β=94.340(13)° γ=102.010(13)°
C8H11N5O3
C8H11N5O3
Acta Crystallographica Section B (2012) 68, 4 431-443
a=10.9182(11)Å b=11.1666(8)Å c=7.9786(9)Å
α=90.00° β=108.346(8)° γ=90.00°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine (1/1)
C5H6N2OS,C4H6N4
Acta Crystallographica Section C (2015) 71, 3
a=6.9996(8)Å b=19.223(2)Å c=17.143(2)Å
α=90° β=90° γ=90°
2,4,6-Triaminopyrimidinium 6-methyl-2-thiouracilate--6-methyl-2-thiouracil--dimethylformamide (1/1/1)
C4H8N5,C5H5N2OS,C5H6N2OS,2(C3H7NO)
Acta Crystallographica Section C (2015) 71, 3
a=8.2680(8)Å b=6.6000(4)Å c=25.043(2)Å
α=90° β=98.887(7)° γ=90°
Nitrofurantoin dimethylacetamide monosolvate
C8H6N4O5,C4H9NO
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=6.6544(5)Å b=7.9842(6)Å c=14.3515(11)Å
α=100.021(6)° β=93.566(6)° γ=99.274(6)°
Nitrofurantoin dimethyl sulfoxide hemisolvate
C8H6N4O5,0.5(C2H6OS)
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=16.1710(11)Å b=13.7985(8)Å c=10.3465(8)Å
α=90.00° β=102.358(6)° γ=90.00°
5-Methoxy-2-thiouracil--dimethylacetamide (1/1)
C5H6N2O2S,C4H9NO
Acta Crystallographica Section C (2014) 70, 2 241-249
a=13.225(3)Å b=6.4726(8)Å c=13.867(3)Å
α=90.00° β=97.170(15)° γ=90.00°